Institute for Systems Biology
Latest From Institute for Systems Biology
The coming of spring has brought a flurry of senior executive moves at companies across Asia including WuXi, Fosun-Kite, Novartis, BGI and Chi-Med.
J&J Innovation's spate of deals led a busy week of deal-making involving many big pharmas. Sanofi exited its inhaled insulin partnership with MannKind, Merck collaborated with Quartet and Complix, Roche partnered with and helped finance C4, and Pfizer signed an immuno-oncology combo trial agreement with Syndax.
The Johnson & Johnson Innovation Center projects include a focus on solid-tumor resections, knee replacement procedures and atrial fibrillation ablation – as well as tracking down biomarkers tied to diabetes and prostate cancer.
Alexandria Real Estate Equities is the largest life science landlord in the US, but it also has a five-member venture team and more than 300 investments on its ledger, mainly in biotherapeutics. Alexandria CEO Joel Marcus discusses the firm's hush-hush portfolio and the evolution of life science workplaces.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.